Screening of psoriatic arthritis by dermatologists – a German nationwide survey
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024
DOI: 10.1111/ddg.15486 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Andreas Pinter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology; University Hospital Frankfurt/Main, Frankfurt/Main, Germany. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AbbVie Deutschland.
Abstract (Originalsprache)
Background and Objectives Up to 30% of psoriasis (PsO) is clinically associated with psoriatic arthritis (PsA). A large proportion of new onset of PsA is diagnosed at a later stage, despite the necessity of early effective treatment to prevent structural damage. This study aimed to identify the routine screening practices used for PsA in patients with PsO. Patients and Methods This non‐interventional, prospective, epidemiological, cross‐sectional study conducted in Germany focuses on screening activity and treatment selection of dermatological practices in suspected PsA. Descriptive statistics and patient characteristics were analyzed for different center types.
Results
One hundred ninety‐five patients from 34 office‐based physicians, five non‐university hospitals, and nine university hospitals were included. Questionnaires or imaging techniques were not routinely used (< 45%). Especially, ultrasounds (≤ 5%) and MRIs (< 6.3%) were rarely performed. Between 30% and 75% of suspected PsA could be confirmed. Referral to rheumatologists and/or appropriate therapy initiation were the most frequent consequences.
Conclusions
Results of this study reflect the status of PsA screening activity by dermatologists. Imaging techniques, particularly ultrasound or MRIs to detect early forms of PsA, were inadequately used, which may have contributed to continued underdiagnoses. Collaboration between dermatologists and rheumatologists should be reviewed with a view to improving effective PsA screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology; University Hospital Frankfurt/Main, Frankfurt/Main, Germany.
- Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.
- Formerly AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
Förderung
- AbbVie Deutschland
Zitieren
APA
Pinter, A., Hofmann, M., Kaufmann, R., Müller-Stahl, J., & König, A. (2024). Screening of psoriatic arthritis by dermatologists – a German nationwide survey. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15486
Vancouver
Pinter A, Hofmann M, Kaufmann R, Müller-Stahl J, König A. Screening of psoriatic arthritis by dermatologists – a German nationwide survey. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15486
BibTeX
@article{Pinter2024,
author = {Pinter, Andreas and Hofmann, Matthias and Kaufmann, Roland and Müller-Stahl, Jutta and König, Anke},
title = {Screening of psoriatic arthritis by dermatologists – a German nationwide survey},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
doi = {10.1111/ddg.15486}
}
EUVIMED